Literature DB >> 35602795

Pericardial Mesothelioma Presenting as Constrictive Pericarditis.

Biraj Shrestha1, Rishin Handa2, Bidhya Poudel3, Rittu Hingorani2.   

Abstract

This case report presents a 60-year-old gentleman with a significant smoking history and possible asbestos exposure who was referred to the emergency department for atrial fibrillation with a rapid ventricular rate and symptoms of heart failure. Labs showed normal brain natriuretic peptide and troponin I. His echocardiography finding suggested constrictive pericarditis with an ejection fraction of 60%. A computed tomography scan was concerning for a pericardial mass. Left and right heart catheterization hinted more toward constrictive physiology; however, some findings were concerning for restrictive physiology. Hence, cardiac magnetic resonance imaging was done, which established the diagnosis of constrictive pericarditis. Pericardiectomy was planned with a maze procedure for atrial fibrillation. However, a malignant neoplasm was seen on a frozen biopsy. Hence, surgery was limited to partial pericardiectomy, as the patient had advanced infiltrative neoplasm that had resulted in constrictive pericarditis. The final pathology report confirmed the diagnosis of malignant pericardial mesothelioma mixed type. Malignancy is usually diagnosed in an advanced stage, like in our case, due to nonspecific initial presentation. A literature review suggests that there is a lack of established consensus on treatment. The response to therapy also seems to be poor and results only in palliation of symptoms, with a median survival of six months from diagnosis despite optimum medical management.
Copyright © 2022, Shrestha et al.

Entities:  

Keywords:  constrictive pericarditis; constrictive physiology; pericardial mass; pericardial mesothelioma; pericardiectomy

Year:  2022        PMID: 35602795      PMCID: PMC9118672          DOI: 10.7759/cureus.24270

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Neoplastic pericarditis.

Authors:  J L Cohen
Journal:  Cardiovasc Clin       Date:  1976

2.  Case Report of Aggressive Primary Pericardial Mesothelioma Presenting as a Constrictive Pericarditis.

Authors:  Gabriel Massicotte; Mathieu Bernier; Marie-Eve Piché; Luce Cantin; Christian Couture
Journal:  Circ Cardiovasc Imaging       Date:  2019-03       Impact factor: 7.792

3.  Pericardial Mesothelioma in a 35-Year-Old Male With Ulcerative Colitis.

Authors:  James Iliff; Nicole K Bart; Simon Ghaly; Emily Granger; Cameron J Holloway
Journal:  Circ Cardiovasc Imaging       Date:  2019-12       Impact factor: 7.792

4.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

Review 5.  Malignant mesothelioma 1982: review of 4710 published cases.

Authors:  G Hillerdal
Journal:  Br J Dis Chest       Date:  1983-10

6.  Pericardial mesothelioma.

Authors:  F P Yilling; R C Schlant; G L Hertzler; R Krzyaniak
Journal:  Chest       Date:  1982-04       Impact factor: 9.410

7.  Pericardial malignant mesothelioma: a latent complication of radiotherapy?

Authors:  Gary R Small; Marianne Nicolson; Keith Buchan; Paul Broadhurst
Journal:  Eur J Cardiothorac Surg       Date:  2008-02-14       Impact factor: 4.191

8.  Primary pericardial mesothelioma presenting as pericardial constriction: a case report.

Authors:  S Suman; P Schofield; S Large
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 9.  Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases.

Authors:  Elizabeth McGehee; David E Gerber; Joan Reisch; Jonathan E Dowell
Journal:  Clin Lung Cancer       Date:  2018-11-29       Impact factor: 4.785

10.  Echocardiographic characteristics of primary malignant pericardial mesothelioma and outcomes analysis: a retrospective study.

Authors:  Lingyun Kong; Ziwang Li; Jingrui Wang; Xiuzhang Lv
Journal:  Cardiovasc Ultrasound       Date:  2018-04-26       Impact factor: 2.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.